Document is current
Any future updates will be listed below
-
Authors
Sharma, Ashish
Parachuri, Nikulaa
Kumar, Nilesh https://orcid.org/0000-0002-7439-2081
Sharma, Rohini
Bandello, Francesco
Kuppermann, Baruch D.
Loewenstein, Anat
- License Information
-
More Information
Article History
Received: 26 March 2020
Revised: 8 April 2020
Accepted: 8 April 2020
First Online: 21 April 2020
Compliance with ethical standards
:
: AS: Consultant: for Novartis, Allergan, Bayer and Intas. FB: Consultant: Allergan, Bayer, Boehringer- Ingelheim, Fidia Sooft, Hofmann La Roche, Novartis, NTC Pharma, Sifi, Thrombogenics, Zeiss. BDK: Clinical Research: Alcon, Alimera, Allegro, Allergan, Apellis, Clearside, Genentech, GSK, Ionis, jCyte, Novartis, Regeneron, ThromboGenics; Consultant: Alimera, Allegro, Allergan, Cell Care, Dose, Eyedaptic, Galimedix, Genentech, Glaukos, Interface Biologics, jCyte, Novartis, Ophthotech, Regeneron, Revana, Theravance Biopharma. AL reports other from Allergan, other from Novartis, other from Roche, other from Notal Vision, other from Forsights labs, other from Beyeonics, other from Bayer Health Care. NK, NP and RS: None
